Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2024-12-10 | 2024-12-10 |
| Drug Identification Number | 02387468 | 02387468 |
| Brand name | LABETALOL HYDROCHLORIDE INJECTION, USP | LABETALOL HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | LABETALOL HYDROCHLORIDE INJECTION, USP | LABETALOL HYDROCHLORIDE INJECTION, USP |
| Company Name | MYLAN PHARMACEUTICALS ULC | MYLAN PHARMACEUTICALS ULC |
| Ingredients | LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE |
| Strength(s) | 5MG | 5MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 20ML 1VL | 20ML 1VL |
| ATC code | C07AG | C07AG |
| ATC description | BETA BLOCKING AGENTS | BETA BLOCKING AGENTS |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | ||
| Actual discontinuation date | 2023-01-10 | 2023-01-10 |
| Remaining supply date | 2019-01-31 | 2019-01-31 |
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | ||
| Health Canada comments | Discontinued 2023-01-10-The last lots and expiry dates are 760813/31-Jan-2018 - Reported in shortage ID 78454 | Discontinued 2023-01-10-The last lots and expiry dates are 760813/31-Jan-2018 - Reported in shortage ID 78454 |